Form 4 for EDIT Editas Medicine, Inc.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001415889-23-002603 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-15 | 2023-02-13 | EDIT | ROBERTSON MICHELLE | EVP, CFO | S - Sale | $9.67 | -4,287 | 76.2K | -5% | -$41.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 4,287 | $9.67 | 76,243 | D | — | — |